Entrada Therapeutics, Inc. (TRDA) Earnings
Entrada Therapeutics, Inc. is expected to report next earnings on November 5, 2026 (in NaN days), with a consensus EPS estimate of $-0.98. TRDA has beaten EPS estimates in 5 of its last 12 reported quarters (average surprise -4.0% over the last four).
Next earnings
Nov 5, 2026in NaN days
EPS est $-0.98 · Revenue est $2M
Track record
Beat EPS in 5 of 12 quarters
Avg surprise -4.0% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 5, 2026 | $-0.97 | $-1.01 | -3.7% | $898000 | -61.4% |
| May 7, 2026 | $-1.06 | $-0.95 | +10.4% | $875000 | -70.0% |
| Nov 6, 2025 | $-1.04 | $-1.06 | -1.9% | $2M | -81.0% |
| Aug 6, 2025 | $-0.86 | $-1.04 | -20.9% | $2M | -75.1% |
| May 8, 2025 | $-0.78 | $-0.42 | +46.2% | $21M | +110.4% |
| Feb 27, 2025 | $-0.66 | $0.03 | +104.5% | $37M | +185.0% |
| Mar 13, 2024 | $-0.07 | $-0.29 | -314.3% | $42M | +76.6% |
| Mar 6, 2023 | $-0.84 | $-0.79 | +6.0% | — | — |
| Aug 11, 2022 | $-0.72 | $-0.74 | -2.8% | — | — |
| May 12, 2022 | $-0.65 | $-0.69 | -6.2% | — | — |
| Mar 15, 2022 | $-1.28 | $-0.89 | +30.5% | — | — |
| Dec 9, 2021 | $-0.87 | $-9.78 | -1024.1% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.